Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.33+0.01 (+4.05%)
Close on Nov 17, 2026Market cap $2.74MP/E –Yield –
Earnings
Q/C Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Q/C Technologies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2018ended Sep 30, 2018 | Nov 15, 2018before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Q/C Technologies has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Q/C Technologies puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Q/C Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- News
- News
- Update
- Update
- Update
- Update
- Update
- News
- Update
- Update
- News
- News
- Update
- Update
See a number that looks wrong?